Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)

This study is currently recruiting participants.

Verified October 2012 by Fudan University

Study NCT01287624 Information provided by Fudan University

First Received on January 31, 2011. Last Updated on October 5, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Cancer

Additional conditions recognized in this trial

Breast Neoplasms

More general conditions related to this trial

Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

Interventions listed in this trial

Additional drug interventions recognized in this trial

Cisplatin
Gemcitabine
Paclitaxel

More general drug interventions related to this trial

Sponsors listed in this trial